Functional Restoration of the Optic Nerve After Disease or Damage
Functional Restoration of the Optic Nerve After Disease or Damage
批准号:
7531030
负责人:
Dong Feng Chen
金额:
$48.13万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-12-01 至 2010-11-30
关键词:
AdultAgeAnimalsAppearanceAstrocytesAxonAxotomyBehaviorBindingBiological AssayBlindnessBrainCellsCellular biologyCentral Nervous System DiseasesCicatrixCuesDataDependovirusDevelopmentDiseaseDominant-Negative MutationEmbryoEmbryonic DevelopmentEventEvoked PotentialsEyeFailureFutureGeneticGenetic EngineeringGlaucomaGlial Fibrillary Acidic ProteinGrowth InhibitorsInjuryIpsilateralKnockout MiceLaboratoriesLeadMapsMidbrain structureModelingMultiple SclerosisMusMutant Strains MiceMyelinNatural regenerationNeonatalNerveNeuroanatomyNeuronsOptic NerveOptic Nerve InjuriesOptic NeuritisOptic tract structureOpticsPathway interactionsProteinsReceptor Protein-Tyrosine KinasesRecoveryResearchRetinaRetinal Ganglion CellsRoleSideSignal TransductionSmall Interfering RNASuggestionSynapsesTestingTimeTransplantationTraumaVimentinVisionVisualVisual evoked cortical potentialagedaxon growthbehavior testfunctional restorationgenetic manipulationgenetic technologyglial cell developmentmouse modelnovel strategiesoptic nerve disorderoptic nerve regenerationoverexpressionpostnatalpreventreceptorregenerativerelating to nervous systemrepairedrestorationsynaptogenesistooltreatment strategy
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The long-term objectives of this research plan are to combine approaches of neuroanatomy, cellular biology and mouse behavior tests to probe for mechanisms regulating optic nerve regeneration and restoring vision after injury or diseases. Optic nerve damage is a major feature of several blinding diseases, such as glaucoma, optic neuropathy, and trauma. Finding ways to rescue retinal ganglion cells from degeneration and to promote optic nerve regrowth are crucial to the development of efficacious treatment for these conditions. Previously, using the established model of optic nerve axotomy and mouse genetic technology, we identified two barriers to optic nerve regeneration the loss of Bcl-2 expression and maturation of astrocytes and their acquisition of the ability to form glial scars. By eliminating these two barriers demonstrated for the first time successful optic nerve re-elongation into the brain targets, up to postnatal day 14 (P14) in mice. Interestingly, regenerating axons in the postnatal mice entered the wrong (ipsilateral) side of the brain and innervated the visual targets in there. However, the regeneration fails consistently if the injury is incurred after P14, suggestion development of additional barriers to nerve regrowth at this age. The key remaining questions are: (1) what is the additional barrier to optic nerve regeneration that is developed after P14 and whether successful regeneration of the severed optic nerve can be achieved in the adult, and (2) whether regenerated axons are capable of establishing a topographic map and functional synapses with target neurons and in turn restoring vision. Recent studies in my laboratory implicate that appearance of the third and likely the last barrier to optic nerve regeneration is related to the development of CNS myelin. We hypothesize that the three barriers to optic nerve regeneration include the loss of Bcl-2 expression by retinal ganglion cells, development of glial scars, and appearance of CNS myelin; simultaneous elimination of the three barriers will allow optic nerve regeneration and restoration of vision in the adult. The three specific aims of this research plan includes: (1) To determine if simultaneous eliminating the three barriers to retinal ganglion axonal regrowth will enable optic nerve regeneration in the adult. (2) To determine a role for EphB1 in directing the ipsilateralization projection of retinal ganglion cell axons during regeneration, using the model of EphB1 knockout mice. (3) To investigate whether regenerated RGC axons are capable of establishing topographically ordered functional connections that can lead to vision restoration, using neuroanatomy, visual evoked potential, and animal behavioral tests. The results of this study may lead to a novel strategy for using neural transplantation to treat blindness and other CNS diseases.
Project Narrative: Failure of optic nerve injury to be repaired is a major feature of several blinding diseases, including glaucoma, optic neuritis, and multiple sclerosis, as well as trauma. Our present research plan is proposed to identify and alleviate all barriers to optic nerve regeneration. The results of these proposed studies will open the door for future development of treatment strategies for optic nerve damage after disease or injury.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Histone and DNA methyltransferases in optic nerve regeneration
-
批准号:10432811
-
项目类别:
-
资助金额:$24.63万
-
财政年份:2022
-
负责人:Dong Feng Chen
-
依托单位:
Histone and DNA methyltransferases in optic nerve regeneration
-
批准号:10612888
-
项目类别:
-
资助金额:$29.55万
-
财政年份:2022
-
负责人:Dong Feng Chen
-
依托单位:
Innate and Adaptive Immunity in the Pathogenesis of Glaucoma
-
批准号:10298994
-
项目类别:
-
资助金额:$76.04万
-
财政年份:2021
-
负责人:Dong Feng Chen
-
依托单位:
Innate and Adaptive Immunity in the Pathogenesis of Glaucoma
-
批准号:10686336
-
项目类别:
-
资助金额:$71.78万
-
财政年份:2021
-
负责人:Dong Feng Chen
-
依托单位:
Innate and Adaptive Immunity in the Pathogenesis of Glaucoma
-
批准号:10715564
-
项目类别:
-
资助金额:$50.44万
-
财政年份:2021
-
负责人:Dong Feng Chen
-
依托单位:
Innate and Adaptive Immunity in the Pathogenesis of Glaucoma
-
批准号:10584665
-
项目类别:
-
资助金额:$18.13万
-
财政年份:2021
-
负责人:Dong Feng Chen
-
依托单位:
The 7th Military Vision Symposium on Ocular Readiness for Military Conflicts and Civilian Casualties
-
批准号:10156646
-
项目类别:
-
资助金额:$4.0万
-
财政年份:2021
-
负责人:Dong Feng Chen
-
依托单位:
Innate and Adaptive Immunity in the Pathogenesis of Glaucoma
-
批准号:10472729
-
项目类别:
-
资助金额:$69.63万
-
财政年份:2021
-
负责人:Dong Feng Chen
-
依托单位:
The Molecular Basis Underlying Optic Nerve Growth in Development and Regeneration
-
批准号:9113192
-
项目类别:
-
资助金额:$49.25万
-
财政年份:2016
-
负责人:Dong Feng Chen
-
依托单位:
Development of a Next Generation Visual Performance Assessment System for Rodents
-
批准号:9920144
-
项目类别:
-
资助金额:$69.17万
-
财政年份:2015
-
负责人:Dong Feng Chen
-
依托单位:
Biological Inquiry into the Mechanisms and Neuroprotective Strategy for TBI
-
批准号:7888246
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Dong Feng Chen
-
依托单位:
Glial Modulation of Cortical Development and Drug of Abuse-induced Brain Damage
-
批准号:7740482
-
项目类别:
-
资助金额:$28.88万
-
财政年份:2009
-
负责人:Dong Feng Chen
-
依托单位:
Biological Inquiry into the Mechanisms and Neuroprotective Strategy for TBI
-
批准号:7748031
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Dong Feng Chen
-
依托单位:
Biological Inquiry into the Mechanisms and Neuroprotective Strategy for TBI
-
批准号:8668986
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Dong Feng Chen
-
依托单位:
Functional Restoration of the Optic Nerve After Disease or Damage
-
批准号:7751235
-
项目类别:
-
资助金额:$48.41万
-
财政年份:2007
-
负责人:Dong Feng Chen
-
依托单位:
Functional Restoration of the Optic Nerve After Disease or Damage
-
批准号:7379844
-
项目类别:
-
资助金额:$48.63万
-
财政年份:2007
-
负责人:Dong Feng Chen
-
依托单位:
MOLECULAR MECHANISMS UNDERLYING OPTIC NERVE REGENERATION
-
批准号:6384873
-
项目类别:
-
资助金额:$36.45万
-
财政年份:2000
-
负责人:Dong Feng Chen
-
依托单位:
MOLECULAR MECHANISMS UNDERLYING OPTIC NERVE REGENERATION
-
批准号:6635700
-
项目类别:
-
资助金额:$37.2万
-
财政年份:2000
-
负责人:Dong Feng Chen
-
依托单位:
MOLECULAR MECHANISMS UNDERLYING OPTIC NERVE REGENERATION
-
批准号:6090421
-
项目类别:
-
资助金额:$39.07万
-
财政年份:2000
-
负责人:Dong Feng Chen
-
依托单位:
MOLECULAR MECHANISMS UNDERLYING OPTIC NERVE REGENERATION
-
批准号:6518677
-
项目类别:
-
资助金额:$34.8万
-
财政年份:2000
-
负责人:Dong Feng Chen
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: